circulating tumor DNA
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients
The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control.
F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies
F-star will use the ctDNA assay to identify potential early biomarkers of clinical efficacy and evaluate treatment response for late-stage solid tumors.
The company expects to launch testing for advanced cancer patients this year, with studies now running to expand to cancer screening and monitoring applications.
Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows
Researchers found patients who had remaining ctDNA after surgery and adjuvant chemo were 12 times more likely to experience recurrence than ctDNA-negative patients.